드러그인포 약품 상세정보

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

비급여
[상병코드조회]
[질병코드집 다운로드] [우리집건강주치의 바로가기]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

무색의 투명한 애체가 흡착된 백색린트포 [제형정보 확인]

포장·유통단위

30매

보관방법

기밀용기, 실온보관

약리작용

[조회]

효능효과

[적응증 별 검색]

족부백선(무좀), 고부백선(완선), 소수포성반상백선
[Drugbank 의 성분정보열람]
[Clotrimazole][Diphenhydramine][Lidocaine]

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
통상 성인의 경우 1일 2-3회 사용하되, 1회 1매-수매씩 환부에 닦아내듯이 바른다.

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

주요약물 상호작용

[보기]

금기

* 다음 부위에는 바르지 말것

눈주위, 점막등
습진, 음부습진

신중투여

알레르기

환부가 광범위한 사람
습윤 또는 진무름이 심한 사람
유유아
의사의 치료를 받고 있는 사람

일반적 주의

* 사용시 다음 사항에 주의할 것

정해진 용법, 용량을 잘 지킬것
환부나 기타 주위가 오염되면 사용하지 말것
소아에게 사용할 경우에는 보호자의 지도, 감독하에 사용할것
눈에 들어가지 않도록 주의할것, 만일 눈에 들어간 경우에는 물로 씻고, 즉시 안과의사에게 진료를 받을것
이 약은 외용으로만 사용하고 내복하지 말것

* 사용중 또는 사용후에 다음 사항에 주의할것

이 약의 사용에 의하여 발진, 발적, 종창, 가려움증 등의 증상이 나타날 경우에는 사용을 중지하고 의사 또는 약사와 상의할 것
2주이상 사용하여도 증상의 개선이 나타나지 않을 경우에는 사용을 중지하고 의사 또는 약사와 상의할 것

보관 및 취급상의 주의

어린이의 손이 닿지 않는곳에 보관할 것
직사일광을 피하고 될 수 있는대로 서늘한 곳에 밀전하여 보관할 것
오용을 막고 품질의 보존을 위해서 다른 용기에 바꾸어 넣지 않는다.

Related FDA Approved Drug

기준 성분:LIDOCAINE
AKTEN (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE (LIDOCAINE)
ALPHACAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ANESTACON (LIDOCAINE HYDROCHLORIDE)
DECADRON W/ XYLOCAINE (DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE)
DENTIPATCH (LIDOCAINE)
DUOCAINE (BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE)
EMBOLEX (DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE)
EMLA (LIDOCAINE; PRILOCAINE)
IONTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LANABIOTIC (BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
LARYNG-O-JET KIT (LIDOCAINE HYDROCHLORIDE)
LARYNGOTRACHEAL ANESTHESIA KIT (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE (LIDOCAINE)
LIDOCAINE AND PRILOCAINE (LIDOCAINE; PRILOCAINE)
LIDOCAINE AND TETRACAINE (LIDOCAINE; TETRACAINE)
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCATON (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDODERM (LIDOCAINE)
LIDOPEN (LIDOCAINE HYDROCHLORIDE)
LIDOSITE TOPICAL SYSTEM KIT (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN FORTE (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN STANDARD (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LTA II KIT (LIDOCAINE HYDROCHLORIDE)
OCTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ORAQIX (LIDOCAINE; PRILOCAINE)
PEDIATRIC LTA KIT (LIDOCAINE HYDROCHLORIDE)
ROCEPHIN KIT (CEFTRIAXONE SODIUM; LIDOCAINE)
SYNERA (LIDOCAINE; TETRACAINE)
TERRAMYCIN (LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE)
XYLOCAINE (LIDOCAINE)
XYLOCAINE 1.5% W/ DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 4% PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 5% W/ GLUCOSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL WITH EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
XYLOCAINE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ZINGO (LIDOCAINE HYDROCHLORIDE)
기준 성분:GLYCYRRHETIC ACID
기준 성분:DIPHENHYDRAMINE HYDROCHLORIDE
ADVIL PM (DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN)
AMBENYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
AMBODRYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE)
ANTITUSSIVE (DIPHENHYDRAMINE HYDROCHLORIDE)
BELDIN (DIPHENHYDRAMINE HYDROCHLORIDE)
BELIX (DIPHENHYDRAMINE HYDROCHLORIDE)
BENADRYL (DIPHENHYDRAMINE HYDROCHLORIDE)
BENADRYL PRESERVATIVE FREE (DIPHENHYDRAMINE HYDROCHLORIDE)
BENYLIN (DIPHENHYDRAMINE HYDROCHLORIDE)
BROMANYL (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE (BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE)
DIBENIL (DIPHENHYDRAMINE HYDROCHLORIDE)
DIPHEN (DIPHENHYDRAMINE HYDROCHLORIDE)
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE (DIPHENHYDRAMINE HYDROCHLORIDE)
HYDRAMINE (DIPHENHYDRAMINE HYDROCHLORIDE)
SILPHEN (DIPHENHYDRAMINE HYDROCHLORIDE)
VICKS FORMULA 44 (DIPHENHYDRAMINE HYDROCHLORIDE)
기준 성분:CLOTRIMAZOLE
CLOTRIMAZOLE (CLOTRIMAZOLE)
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE)
GYNE-LOTRIMIN (CLOTRIMAZOLE)
GYNE-LOTRIMIN 3 (CLOTRIMAZOLE)
GYNE-LOTRIMIN 3 COMBINATION PACK (CLOTRIMAZOLE)
GYNE-LOTRIMIN COMBINATION PACK (CLOTRIMAZOLE)
GYNIX (CLOTRIMAZOLE)
LOTRIMIN (CLOTRIMAZOLE)
LOTRIMIN AF (CLOTRIMAZOLE)
LOTRISONE (BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE)
MYCELEX (CLOTRIMAZOLE)
MYCELEX-7 (CLOTRIMAZOLE)
MYCELEX-7 COMBINATION PACK (CLOTRIMAZOLE)
MYCELEX-G (CLOTRIMAZOLE)
TRIVAGIZOLE 3 (CLOTRIMAZOLE)

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
BIT 약효분류	외용 항진균제 (Antifungals : Skin & Mucous Membrane)
ATC 코드	Imidazole and triazole derivatives / D01AC [코드분류상세설명] [ATC코드예측]
복지부분류코드	265 (기생성 피부질환용제 )
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	비급여 [상병코드조회] [질병코드집 다운로드]
제품성상	무색의 투명한 애체가 흡착된 백색린트포 [제형정보 확인]
포장·유통단위	30매
보관방법	기밀용기, 실온보관

복약정보

항목

내용

LACTmed 바로가기

[바로가기]

약리작용

유료정보입니다.

복약지도

유료정보입니다.

임부에대한투여

*	전체임신 기간별로 여러등급이 존재할 수 있으며 가장 위험도가 높은 정보만 보여집니다. 단, 복합제의 경우 모든 복합제성분에 대한 임부투여등급이 표시된것은 절대 아니며 표시된것중에 가장 위험도가 높은 정보만 나타납니다.

FDA : C등급
(clotrimazole; )

*	상기 임부투여에 대한 정보는 전산처리 되면서 입력 오류 가능성이 존재합니다. 오류 가능성을 최소화하기 위하여 많은 노력을 기울이고 있으나, 그 정확성에 대하여 확신을 드릴 수 없습니다. 이에 대해 회사는 책임을 지지 않습니다.
*	반드시 공신력 있는 문헌을 다시 한번 참고 하시기 바라며 의사 또는 약사의 판단에 따라 투여여부가 결정되어야 합니다.

신장애, 간장애시
용량조절

유료정보입니다.

Pharmacokinetics

유료정보입니다.

병용금기 및 연령대금기 근거조회

[병용금기 및 연령대금기 근거조회]

보관상 주의

조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Diphenhydramine에 대한 독성정보 : 정보보기 L-Menthol에 대한 독성정보 : 정보보기 Lidocaine에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Clotrimazole에 대한 Mechanism_Of_Action 정보 Clotrimazole interacts with yeast 14-α demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the membrane. In this way, clotrimazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Clotrimazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel. Diphenhydramine에 대한 Mechanism_Of_Action 정보 Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Lidocaine에 대한 Mechanism_Of_Action 정보 Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action.
Pharmacology	Clotrimazole에 대한 Pharmacology 정보 Clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity, inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Betamethasone and clotrimazole are used together to treat cutaneous tinea infections. In studies in fungal cultures, the minimum fungicidal concentration of clotrimazole caused leakage of intracellular phosphorous compounds into the ambient medium with concomitant breakdown of cellular nucleic acids, and accelerated potassium etflux. Both of these events began rapidly and extensively after addition of the drug to the cultures. The primary action of clotrimazole is against dividing and growing organisms. Diphenhydramine에 대한 Pharmacology 정보 Diphenhydramine is an antihistamine of the ethanolamine class. Ethanolamine antihistamines have significant antimuscarinic activity and produce marked sedation in most patients. In addition to the usual allergic symptoms, the drug also treats irritant cough and nausea, vomiting, and vertigo associated with motion sickness. It also is used commonly to treat drug-induced extrapyramidal symptoms as well as to treat mild cases of Parkinson's disease. Rather than preventing the release of histamine, as do cromolyn and nedocromil, diphenhydramine competes with free histamine for binding at HA-receptor sites. Diphenhydramine competitively antagonizes the effects of histamine on HA-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Ethanolamine derivatives have greater anticholinergic activity than do other antihistamines, which probably accounts for the antidyskinetic action of diphenhydramine. This anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown. Lidocaine에 대한 Pharmacology 정보 Lidocaine is an anesthetic agent indicated for production of local or regional anesthesia and in the treatment of ventricular tachycardia occurring during cardiac manipulation, such as surgery or catheterization, or which may occur during acute myocardial infarction, digitalis toxicity, or other cardiac diseases. The mode of action of the antiarrhythmic effect of Lidocaine appears to be similar to that of procaine, procainamide and quinidine. Ventricular excitability is depressed and the stimulation threshold of the ventricle is increased during diastole. The sinoatrial node is, however, unaffected. In contrast to the latter 3 drugs, Lidocaine in therapeutic doses does not produce a significant decrease in arterial pressure or in cardiac contractile force. In larger doses, lidocaine may produce circulatory depression, but the magnitude of the change is less than that found with comparable doses of procainamide.
Metabolism	Clotrimazole에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 11A1 (CYP11A1)Cytochrome P450 1A2 (CYP1A2)Cytochrome P450 2D6 (CYP2D6) Diphenhydramine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 2D6 (CYP2D6)Cytochrome P450 3A4 (CYP3A4) Lidocaine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 1A2 (CYP1A2)Cytochrome P450 2D6 (CYP2D6)
Protein Binding	Clotrimazole에 대한 단백결합 정보 90% Diphenhydramine에 대한 단백결합 정보 98 to 99% Lidocaine에 대한 단백결합 정보 60-80%
Half-life	Clotrimazole에 대한 반감기 정보 2 hours Diphenhydramine에 대한 반감기 정보 1-4 hours Lidocaine에 대한 반감기 정보 109 minutes
Absorption	Clotrimazole에 대한 Absorption 정보 Poorly and erratically absorbed orally, minimal vaginal or topical absorption. Diphenhydramine에 대한 Absorption 정보 Quickly absorbed with maximum activity occurring in approximately one hour. Lidocaine에 대한 Absorption 정보 Information derived from diverse formulations, concentrations and usages reveals that lidocaine is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent.
Pharmacokinetics	Lidocaine의 약물동력학자료 효과발현시간 (1회 bolus 용량으로서) : 45-90초 작용지속시간 : 10-25분 분포 (Vd) : 많은 요인에 따라 변화되며, 울혈성 심부전과 간질환에서는 분포용적이 감소됨 단백결합 : 60-80%, α₁-acid glycoprotein과 결합 대사 : 간에서 90% 대사 활성형 대사체인 monoethylglycinexylidide(MEGX)와 glycinexylidide(GX)가 축적되어 중추신경계 독성을 유발할 수 있다. 반감기 (biphasic) : 울혈성 심부전, 간질환, 쇼크, 중증의 신질환에서 증가 초기 : 7-30분 말기 : 영아, 미숙아 : 3.2시간, 성인 : 1.5-2시간 Diphenhydramine HCl의 약물동력학자료 최고 진정 효과 : 1-3 시간 작용지속시간 : 4-7 시간 흡수 : 초회통과효과가 있어서 40 - 60 % 정도가 전신순환으로 들어감 대사 : 대부분 간대사, 일부는 폐와 신장에서도 대사 단백결합 : 78% 최고혈중농도 도달시간 : 2-4 시간 L-menthol의 약물동력학자료 소실 : 흡수된 약물은 glucuronide 포합체로서 소변 및 담즙을 통해 배설된다. Clotrimazole의 약물동력학자료 흡수 : 외용 : 정상 피부를 통해서는 거의 흡수되지 않는다. 혈중최고농도 도달시간 : Troches : 타액 농도 : 3시간 이내 질 크림 : 질내 농도 : 8-24 시간 이내 질정 : 질내 농도 : 1-2 일 이내 소실 : 대사체로 담즙배설
Biotransformation	Clotrimazole에 대한 Biotransformation 정보 Hepatic (metabolized to inactive metabolites) Diphenhydramine에 대한 Biotransformation 정보 Hepatic and renal Lidocaine에 대한 Biotransformation 정보 Primarily hepatic.
Toxicity	Clotrimazole에 대한 Toxicity 정보 Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps. Diphenhydramine에 대한 Toxicity 정보 LD₅₀=500 mg/kg (orally in rats). Considerable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death. Lidocaine에 대한 Toxicity 정보 The oral LD 50 of lidocaine HCl in non-fasted female rats is 459 (346-773) mg/kg (as the salt) and 214 (159-324) mg/kg (as the salt) in fasted female rats. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.
Drug Interactions	Clotrimazole에 대한 Drug_Interactions 정보 Not Available Diphenhydramine에 대한 Drug_Interactions 정보 Atomoxetine The CYP2D6 inhibitor could increases the effect and toxicity of atomoxetineDonepezil Possible antagonism of actionGalantamine Possible antagonism of actionMesoridazine Increased risk of cardiotoxicity and arrhythmiasRivastigmine Possible antagonism of actionThioridazine Increased risk of cardiotoxicity and arrhythmias Lidocaine에 대한 Drug_Interactions 정보 Not Available
CYP450 Drug Interaction	[CYP450 Table직접조회]
Food Interaction	Clotrimazole에 대한 Food Interaction 정보 Not Available Diphenhydramine에 대한 Food Interaction 정보 Avoid alcohol.Take with food. Lidocaine에 대한 Food Interaction 정보 Not Available
Drug Target	[Drug Target]
Description	Clotrimazole에 대한 Description 정보 An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [PubChem] Diphenhydramine에 대한 Description 정보 A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Lidocaine에 대한 Description 정보 A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. [PubChem]
Dosage Form	Clotrimazole에 대한 Dosage_Form 정보 Cream IntravaginalCream Topical Diphenhydramine에 대한 Dosage_Form 정보 Capsule OralCream TopicalElixir OralLiquid IntramuscularLiquid IntravenousLiquid OralLozenge OralStrip OralSyrup OralTablet OralTablet, chewable Oral Lidocaine에 대한 Dosage_Form 정보 Aerosol TopicalAerosol, metered TopicalCream TopicalGel TopicalJelly TopicalJelly UrethralLiquid BuccalLiquid DentalLiquid InfiltrationLiquid IntravenousLiquid OralLiquid TopicalLotion TopicalOintment TopicalSolution InfiltrationSolution IntramuscularSolution IntravenousSolution OralSolution TopicalSpray TopicalSwab Topical
Drug Category	Clotrimazole에 대한 Drug_Category 정보 Anti-Infective Agents, LocalAntifungal AgentsGrowth Inhibitors Diphenhydramine에 대한 Drug_Category 정보 AnestheticsAnesthetics, LocalAnti-Allergic AgentsAntidyskineticsAntiemeticsAntiparkinson AgentsAntipruriticsAntitussivesEthanolamine DerivativesHistamine H1 AntagonistsHypnotics and Sedatives Lidocaine에 대한 Drug_Category 정보 AnestheticsAnesthetics, LocalAnti-Arrhythmia AgentsAntiarrhythmic Agents
Smiles String Canonical	Clotrimazole에 대한 Smiles_String_canonical 정보 ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1 Diphenhydramine에 대한 Smiles_String_canonical 정보 CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1 Lidocaine에 대한 Smiles_String_canonical 정보 CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Smiles String Isomeric	Clotrimazole에 대한 Smiles_String_isomeric 정보 ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1 Diphenhydramine에 대한 Smiles_String_isomeric 정보 CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1 Lidocaine에 대한 Smiles_String_isomeric 정보 CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
InChI Identifier	Clotrimazole에 대한 InChI_Identifier 정보 InChI=1/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H Diphenhydramine에 대한 InChI_Identifier 정보 InChI=1/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 Lidocaine에 대한 InChI_Identifier 정보 InChI=1/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)/f/h15H
Chemical IUPAC Name	Clotrimazole에 대한 Chemical_IUPAC_Name 정보 1-[(2-chlorophenyl)-di(phenyl)methyl]imidazole Diphenhydramine에 대한 Chemical_IUPAC_Name 정보 2-[di(phenyl)methoxy]-N,N-dimethylethanamine Lidocaine에 대한 Chemical_IUPAC_Name 정보 2-diethylamino-N-(2,6-dimethylphenyl)acetamide
Drug-Induced Toxicity Related Proteins	DOCA 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:Aquaporin-2 Drug:DOCA Toxicity:hypertension. [바로가기] LIDOCAINE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:glucose-regulated protein Drug:lidocaine Toxicity:intestinal disorder. [바로가기] Replated Protein:Alkaline phosphatase Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기] Replated Protein:C-reactive protein Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:C-reactive protein Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기] Replated Protein:Alpha-1-acid glycoprotein Drug:lidocaine Toxicity:lidocaine tolerance. [바로가기] Replated Protein:Gamma-glutamyltranspeptidase Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:Alkaline phosphatase Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:Gamma-glutamyltranspeptidase Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기]

사용자컨텐츠

항목

내용

핵심 요약 정보